Keywords: Breast, Breast
Motivation: MRI is expected to be a new surrogate marker of prognosis that can replace pathological complete response (pCR) for breast cancer patients who underwent neoadjuvant systemic treatment (NST).
Goal(s): MRI is expected to be a new surrogate marker of prognosis that can replace pathological complete response (pCR) for breast cancer patients who underwent neoadjuvant systemic treatment (NST)
Approach: Survival analysis was performed for disease-free survival using Kaplan-Meier method.
Results: DWI score after NST of breast cancer was associated with DFS, in particular triple-negative, HER2-positive, and luminal-HER2 subtype.
Impact: The DWI / kinetic score obtained from MRI after neoadjuvant systemic treatment (NST) were associated with disease-free survival (DFS), especially among triple-negative, HER2-positive, and luminal/HER2 subtype. The DWI score may be a biomarker for prognosis of breast cancer patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords